OpenVSafe by OpenVAERS
Search V-safe

BKZ-28339-82804

2 vaccinations 6 coded responses 14 check-ins 6 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
773 / TX
Registered
2021-04-06
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2115986 (opens in a new window) high 11 / 11 2 1 of 2 VAERS symptoms same dose (2) TX matches 2021-11-11 / 2021-11-12 / 2022-02-16
received the same day as the last call
 case 211786

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-04-06
    Registered in v-safe
  2. 2021-04-06
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-04-06
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-07
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vertigo — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Vertigo
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-07
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  7. 2021-04-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Anxiety — Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  9. 2021-04-20
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  10. 2021-04-27
    Survey response — day 21, single dose
    MedDRA: Anxiety, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Severe anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-04
    Health check-in — day 28, single dose
    Feeling: Good
    Adult check-in
  12. 2021-05-11
    Health check-in — day 35, single dose
    Feeling: Good
    Adult check-in
  13. 2021-05-18
    Survey response — day 42, single dose
    MedDRA: Anxiety — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-21
  15. 2021-05-24
  16. 2021-05-24
  17. 2021-05-24
    Call successful
    Completed over the phone
  18. 2021-07-08
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  19. 2021-10-07
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  20. 2021-11-11
    Dose 2 — Pfizer-BioNTech
  21. 2022-02-15
    Survey response — 3 months, dose 2
    MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Pregnancy and miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-02-15
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  23. 2022-02-16
    Call successful
    Completed over the phone
  24. 2022-11-13
    Survey response — 12 months, dose 2
    MedDRA: Hormone level abnormal, Infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Hormone imbalances, chronic infections
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-06Janssen/Johnson & Johnson
22021-11-11Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-04-07 Successful
2021-05-24
 Completed over the phone
2022-02-15 Successful
2022-02-16
 Completed over the phone

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-07

Systemic reaction (other): Vertigo

2021-04-10

Systemic reaction (other): Anxiety

Release 8 — day 21, single dose

2021-04-27

Symptoms: Severe anxiety

Release 8 — day 42, single dose

2021-05-18

Symptoms: Anxiety

Release 11 — 3 months, dose 2

2022-02-15

Symptoms: Pregnancy and miscarriage

Release 12 — 12 months, dose 2

2022-11-13

Symptoms: Hormone imbalances, chronic infections

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDAnxiety ✓ ✓ ✓
SDHormone level abnormal · · ✓
SDInfection · · ✓
SDPre-existing disease ✓ ✓ ✓
SROAnxiety ✓ ✓ ✓
SROVertigo ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…